Norvasc: Effective Blood Pressure Control with Amlodipine
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.84 | $50.25 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $75.38 $69.35 (8%) | 🛒 Add to cart |
| 120 | $0.73 | $100.51 $87.44 (13%) | 🛒 Add to cart |
| 180 | $0.69 | $150.76 $123.62 (18%) | 🛒 Add to cart |
| 270 | $0.66 | $226.14 $177.90 (21%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $301.52 $233.18 (23%) | 🛒 Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.34 | $61.31 (0%) | 🛒 Add to cart |
| 270 | $0.32 | $91.96 $85.43 (7%) | 🛒 Add to cart |
| 360 | $0.30
Best per pill | $122.62 $109.55 (11%) | 🛒 Add to cart |
Norvasc, known generically as amlodipine, is a widely prescribed calcium channel blocker indicated for the management of hypertension and chronic stable angina. As a first-line antihypertensive agent, it functions by relaxing blood vessels, thereby improving blood flow and reducing cardiac workload. Its long half-life supports consistent 24-hour efficacy with once-daily dosing, making it a cornerstone in cardiovascular therapeutic regimens. Trusted by clinicians globally, Norvasc offers a balance of potency, tolerability, and patient adherence.
Features
- Active ingredient: Amlodipine besylate
- Drug class: Dihydropyridine calcium channel blocker
- Available in tablet strengths: 2.5 mg, 5 mg, and 10 mg
- Administration: Oral, once daily
- Onset of action: Gradual, with peak effects at 6–12 hours
- Half-life: 30–50 hours, supporting steady-state concentration
- Bioavailability: 64–90%, not significantly affected by food
Benefits
- Effectively lowers systolic and diastolic blood pressure, reducing cardiovascular risk
- Decreases frequency of angina episodes and need for nitroglycerin use
- Provides smooth 24-hour coverage with a single daily dose, enhancing compliance
- Generally well-tolerated with a favorable side effect profile in most patients
- Suitable for use in diverse patient populations, including those with diabetes or renal impairment
- May be used as monotherapy or in combination with other antihypertensive agents
Common use
Norvasc is primarily indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive drugs. It is also approved for the management of chronic stable angina and vasospastic (Prinzmetal’s) angina. In clinical practice, it is often selected for patients requiring consistent blood pressure control without significant fluctuations, and it is particularly useful in individuals with concomitant conditions where other agents may be less desirable.
Dosage and direction
The recommended initial dose for hypertension or angina in adults is 5 mg once daily, which may be increased to a maximum dose of 10 mg daily based on individual patient response and tolerability. Small or fragile patients, or those with hepatic impairment, may be started on 2.5 mg daily. Dose adjustments should generally occur at 7- to 14-day intervals. Norvasc may be taken with or without food, at approximately the same time each day. Tablets should be swallowed whole with a glass of water; they are not designed to be split, crushed, or chewed.
Precautions
Patients should be monitored for signs of hypotension, especially after initiation or dose titration. Use with caution in patients with severe aortic stenosis, heart failure, or hepatic impairment, as clearance may be reduced. Peripheral edema is a common dose-related side effect and may be more pronounced in elderly patients. Abrupt withdrawal is not associated with rebound hypertension, but discontinuation should be supervised. Patients should avoid grapefruit juice, as it may increase amlodipine levels.
Contraindications
Norvasc is contraindicated in patients with known hypersensitivity to amlodipine or any component of the formulation. It should not be used in cases of cardiogenic shock or clinically significant hypotension. Although rare, caution is advised in patients with a history of severe obstructive coronary artery disease where afterload reduction could theoretically precipitate ischemia.
Possible side effect
Common side effects include peripheral edema, dizziness, flushing, palpitations, and headache. Less frequently, patients may experience fatigue, nausea, abdominal pain, or somnolence. Rare but serious adverse reactions include hypotension, syncope, arrhythmias, and marked peripheral edema. Allergic reactions such as rash, pruritus, or angioedema have been reported in isolated cases.
Drug interaction
Norvasc may interact with other antihypertensive agents, potentially increasing the risk of hypotension. Concurrent use with CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) may elevate amlodipine levels. Simvastatin coadministration should be monitored, as amlodipine can increase simvastatin exposure. Use with sildenafil or other phosphodiesterase inhibitors may augment hypotensive effects. Grapefruit juice should be avoided due to inhibition of CYP3A4.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to compensate for a missed one is not recommended.
Overdose
Overdose may lead to pronounced hypotension and reflex tachycardia. In cases of suspected overdose, cardiovascular monitoring is essential. Treatment is supportive and may include elevation of the lower extremities, administration of intravenous fluids, and vasopressors if necessary. Since amlodipine is highly protein-bound, dialysis is not likely to be beneficial.
Storage
Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual patient needs and responses may vary.
Reviews
Clinical studies and post-marketing surveillance consistently affirm Norvasc’s efficacy and safety profile. It receives high marks from physicians for its reliability in blood pressure management and reduction of angina symptoms. Patient feedback often highlights improved quality of life due to better-controlled hypertension, though some report edema or dizziness. Overall, it remains a trusted option in long-term cardiovascular care.